Transformed mycosis fungoides developing after treatment with alefacept [4]

Journal of the American Academy of Dermatology

Volumn 53, Issue 2, 2005, Pages 355-356

  Schmidt, Adriana ^a   Robbins, Jason ^b   Zic, John ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALEFACEPT; ETRETIN; METHOTREXATE; PREDNISONE; STEROID; TACROLIMUS;

AGED; ANAMNESIS; CASE REPORT; CLINICAL FEATURE; HUMAN; IMMUNOHISTOCHEMISTRY; LETTER; MALE; MYCOSIS FUNGOIDES; PRIORITY JOURNAL; PSORIASIS; SKIN BIOPSY;

EID: 22144467671     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2005.02.043     Document Type: Article

References (5)

1. S.L. Brown, S.K. Gershon, E.T. Edwards, and M.M. Braun Tumor necrosis factor antagonist therapy and lymphoma development: twenty-six cases reported to the Food and Drug Administration Arthritis Rheum 46 2002 3151 3158
2. F. Wolfe, and K. Michaud Lymphoma in rheumatoid arthritis: the effect of methotrexate and anti-tumor necrosis factor therapy in 18,572 patients Arthritis Rheum 50 2004 1740 1751
3. A. Baki, M.F. Demierre, N. Li, and F.M. Foss Transformation in mycosis fungoides: the role of methotrexate J Cutan Med Surg 6 2002 109 116
4. J.A. Pielop, D. Jones, and M. Duvic Transient CD30+ nodal transformation of cutaneous T-cell lymphoma associated with cyclosporine treatment Int J Dermatol 40 2001 505 511
5. G. Krueger, and K. Callis Development and use of alefacept to treat psoriasis J Am Acad Dermatol 49 2003 S87 S97